View in EDS

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

Saved in:
Bibliographic Details
Title: Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.
Authors: Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University Vienna, Vienna, Austria. heinz.gisslinger@meduniwien.ac.at., Klade C; AOP Health, Vienna, Austria., Georgiev P; Medical University of Plovdiv, Plovdiv, Bulgaria., Krochmalczyk D; Teaching Unit of the Hematology Department, University Hospital in Krakow, Krakow, Poland., Gercheva-Kyuchukova L; Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment 'Sveta Marina', Varna, Bulgaria., Egyed M; Department of Internal Medicine II, Kaposi Mor County Teaching Hospital, Kaposvar, Hungary., Dulicek P; Department of Clinical Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Illes A; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pylypenko H; Department of Hematology, Regional Treatment and Diagnostics Hematology Centre, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine., Sivcheva L; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria., Mayer J; Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Yablokova V; Department of Hematology, Yaroslavl Regional Clinical Hospital, Yaroslavl, Russia., Krejcy K; AOP Health, Vienna, Austria., Empson V; AOP Health, Vienna, Austria., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Copenhagen, Denmark., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France.
Corporate Authors: PROUD-PV Study Group
Source: Leukemia [Leukemia] 2023 Oct; Vol. 37 (10), pp. 2129-2132. Date of Electronic Publication: 2023 Aug 26.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37634011
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gisslinger+H%22">Gisslinger H</searchLink>; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University Vienna, Vienna, Austria. heinz.gisslinger@meduniwien.ac.at.<br /><searchLink fieldCode="AU" term="%22Klade+C%22">Klade C</searchLink>; AOP Health, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Georgiev+P%22">Georgiev P</searchLink>; Medical University of Plovdiv, Plovdiv, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Krochmalczyk+D%22">Krochmalczyk D</searchLink>; Teaching Unit of the Hematology Department, University Hospital in Krakow, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Gercheva-Kyuchukova+L%22">Gercheva-Kyuchukova L</searchLink>; Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment 'Sveta Marina', Varna, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Egyed+M%22">Egyed M</searchLink>; Department of Internal Medicine II, Kaposi Mor County Teaching Hospital, Kaposvar, Hungary.<br /><searchLink fieldCode="AU" term="%22Dulicek+P%22">Dulicek P</searchLink>; Department of Clinical Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Illes+A%22">Illes A</searchLink>; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Department of Hematology, Regional Treatment and Diagnostics Hematology Centre, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Sivcheva+L%22">Sivcheva L</searchLink>; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Yablokova+V%22">Yablokova V</searchLink>; Department of Hematology, Yaroslavl Regional Clinical Hospital, Yaroslavl, Russia.<br /><searchLink fieldCode="AU" term="%22Krejcy+K%22">Krejcy K</searchLink>; AOP Health, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Empson+V%22">Empson V</searchLink>; AOP Health, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hasselbalch+HC%22">Hasselbalch HC</searchLink>; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kralovics+R%22">Kralovics R</searchLink>; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PROUD-PV+Study+Group%22">PROUD-PV Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2023 Oct; Vol. 37 (10), pp. 2129-2132. <i>Date of Electronic Publication: </i>2023 Aug 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37634011
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-023-02008-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2129
    Titles:
      – TitleFull: Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gisslinger H
      – PersonEntity:
          Name:
            NameFull: Klade C
      – PersonEntity:
          Name:
            NameFull: Georgiev P
      – PersonEntity:
          Name:
            NameFull: Krochmalczyk D
      – PersonEntity:
          Name:
            NameFull: Gercheva-Kyuchukova L
      – PersonEntity:
          Name:
            NameFull: Egyed M
      – PersonEntity:
          Name:
            NameFull: Dulicek P
      – PersonEntity:
          Name:
            NameFull: Illes A
      – PersonEntity:
          Name:
            NameFull: Pylypenko H
      – PersonEntity:
          Name:
            NameFull: Sivcheva L
      – PersonEntity:
          Name:
            NameFull: Mayer J
      – PersonEntity:
          Name:
            NameFull: Yablokova V
      – PersonEntity:
          Name:
            NameFull: Krejcy K
      – PersonEntity:
          Name:
            NameFull: Empson V
      – PersonEntity:
          Name:
            NameFull: Hasselbalch HC
      – PersonEntity:
          Name:
            NameFull: Kralovics R
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1